Evidence map›Paper›PMID 30150556›Full record

ReviewCells2018

Ubiquitin Regulation: The Histone Modifying Enzyme's Story.

Jianlin Wang, Zhaoping Qiu, Yadi Wu

Abstract readReview
In one paragraph

Review in Cells, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Gastric Cancer in the Era of Epigenetics.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Gastric cancer: An epigenetic view.World journal of gastrointestinal oncology · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jianlin WangDepartment of Pharmacology & Nutritional Sciences, University of Kentucky School of Medicine, KY 40506, USA. jianlin.wang@uky.edu.
Zhaoping QiuDepartment of Pharmacology & Nutritional Sciences, University of Kentucky School of Medicine, KY 40506, USA. zhaoping.qiu@uky.edu.
Yadi WuDepartment of Pharmacology & Nutritional Sciences, University of Kentucky School of Medicine, KY 40506, USA. yadi.wu@uky.edu.

Funding

University of Kentucky Center for Cancer MetabolismP20GM121327 · NIGMS · UNIVERSITY OF KENTUCKY · PI Jianhang Jia · 2017 to 2026
$25.0M
Characterize the role of EBF1 in breast cancer progressionR01CA230758 · NCI · UNIVERSITY OF KENTUCKY · PI WU, YADI · 2018 to 2023
$1.7M
NCI NIH HHS R01 CA230758NIGMS NIH HHS P20 GM121327
6 · The paper itself

Abstract

Histone post-translational modifications influence many fundamental cellular events by regulating chromatin structure and gene transcriptional activity. These modifications are highly dynamic and tightly controlled, with many enzymes devoted to the addition and removal of these modifications. Interestingly, these modifying enzymes are themselves fine-tuned and precisely regulated at the level of protein turnover by ubiquitin-proteasomal processing. Here, we focus on recent progress centered on the mechanisms regulating ubiquitination of histone modifying enzymes, including ubiquitin proteasomal degradation and the reverse process of deubiquitination. We will also discuss the potential pathophysiological significance of these processes.

Indexed as

epigenetichistone modifying enzymeprotein degradationubiquitin

Identifiers

PMID30150556
PMCPMC6162602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.